OncoSil Medical secures TGA approval for pancreatic cancer device

​OncoSil Medical has secured the Australian TGA approval for its OncoSil device, permitting its use in the treatment of LAPC alongside gemcitabine-based chemotherapy.

The post OncoSil Medical secures TGA approval for pancreatic cancer device appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.